Brar H S, Greenspoon J S, Platt L D, Paul R H
Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles.
J Reprod Med. 1989 Feb;34(2):173-7.
A retrospective review identified 56 patients with uterine inversion, from July 1977 through June 1986, from weekly obstetric statistics, delivery records and computerized discharge diagnoses. All patients underwent delivery by house officers, midwives or medical students under supervision. An analysis of the data revealed that the risk factors were primiparity, a fundally implanted placenta and delivery of a macrosomic fetus. Also, patients who received oxytocin with or without MgSO4 were at higher risk of puerperal inversion. MgSO4 by itself did not appear to be a risk factor. A placenta attached at the time of inversion appeared to have a protective effect against the development of shock. The use of betamimetics or MgSO4 appeared to be an acceptable alternative to general anesthesia in relaxing the uterus and aiding in its repositioning. Those agents were more likely to be successful in acute cases than in subacute ones and in second-degree inversion than in third-degree.
一项回顾性研究通过每周的产科统计数据、分娩记录和计算机化出院诊断,确定了1977年7月至1986年6月期间56例子宫内翻患者。所有患者均由住院医生、助产士或医学生在监督下进行分娩。数据分析显示,危险因素包括初产、胎盘植入子宫底部和巨大胎儿分娩。此外,使用催产素(无论是否联合硫酸镁)的患者发生产后子宫内翻的风险更高。单独使用硫酸镁似乎不是一个危险因素。子宫内翻时附着的胎盘似乎对休克的发生有保护作用。在松弛子宫和协助子宫复位方面,使用β-拟交感神经药或硫酸镁似乎是全身麻醉的可接受替代方法。这些药物在急性病例中比在亚急性病例中更可能成功,在二度子宫内翻中比在三度子宫内翻中更可能成功。